Stock screener · US · NASDAQ
Filter the global stock universe by sector, market cap, P/E, ROE, dividend yield, and more. Covered tickers show our latest rating, fair value, and upside; data-only tickers still get profile, valuation, profitability, growth, ownership, and market indicators. For curated editorial screens (wide-moat, dividend aristocrats, etc.), see stock lists.
900
rows · refreshed 2026-05-10
| Symbol | Company | Market | Sector | Price | Market cap | P/E | ROE | 1Y return | Analysis |
|---|---|---|---|---|---|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc. Medical Devices | US / NASDAQ | Healthcare | $71.77 | 2.1B | n/a | -164.0% | +115.7% | Data only |
| SRPT | Sarepta Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $19.96 | 2.1B | 31.3x | +4.9% | -45.7% | Data only |
| NBTX | Nanobiotix S.A. Biotechnology | US / NASDAQ | Healthcare | $45.49 | 2.1B | n/a | n/a | +1278.5% | Data only |
| ZLAB | Zai Lab Limited Biotechnology | US / NASDAQ | Healthcare | $18.60 | 2.1B | n/a | -24.2% | -34.4% | Data only |
| NVCR | NovoCure Limited Medical Devices | US / NASDAQ | Healthcare | $17.89 | 2.1B | n/a | -50.0% | +7.4% | Data only |
| TRVI | Trevi Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $14.50 | 2.1B | n/a | -33.6% | +117.7% | Data only |
| STOK | Stoke Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $32.89 | 2B | n/a | -45.6% | +279.8% | Data only |
| TYRA | Tyra Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | $34.32 | 2B | n/a | -39.8% | +275.9% | Data only |
| AAPG | Ascentage Pharma Group International Biotechnology | US / NASDAQ | Healthcare | $21.50 | 2B | n/a | -154.6% | -11.0% | Data only |
| SION | Sionna Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $44.23 | 2B | n/a | -31.8% | +243.4% | Data only |
| ANAB | AnaptysBio, Inc. Biotechnology | US / NASDAQ | Healthcare | $69.30 | 2B | n/a | -24.5% | +428.3% | Data only |
| OMCL | Omnicell, Inc. Health Information Services | US / NASDAQ | Healthcare | $43.82 | 2B | 99.6x | +1.6% | +77.9% | Data only |
| NEOG | Neogen Corporation Medical Devices | US / NASDAQ | Healthcare | $9.05 | 2B | n/a | -25.6% | +52.6% | Data only |
| NTLA | Intellia Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $14.09 | 2B | n/a | -53.5% | +93.3% | Data only |
| PHVS | Pharvaris N.V. Biotechnology | US / NASDAQ | Healthcare | $30.09 | 2B | n/a | -65.2% | +76.0% | Data only |
| INBX | Inhibrx Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | $134 | 2B | n/a | -197.8% | +1110.4% | Data only |
| AUPH | Aurinia Pharmaceuticals Inc. Biotechnology | US / NASDAQ | Healthcare | $15.23 | 2B | 7.0x | +65.0% | +87.8% | Data only |
| TSHA | Taysha Gene Therapies, Inc. Biotechnology | US / NASDAQ | Healthcare | $6.81 | 2B | n/a | -97.3% | +258.4% | Data only |
| MBX | MBX Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | $40.97 | 1.9B | n/a | -25.7% | +278.3% | Data only |
| OCS | Oculis Holding AG Biotechnology | US / NASDAQ | Healthcare | $32.64 | 1.9B | n/a | -73.5% | +77.2% | Data only |
| ASTH | Astrana Health, Inc. Medical Care Facilities | US / NASDAQ | Healthcare | $39.30 | 1.9B | 64.3x | +5.7% | +22.3% | Data only |
| SNDX | Syndax Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $21.49 | 1.9B | n/a | -189.5% | +115.1% | Data only |
| MESO | Mesoblast Limited Biotechnology | US / NASDAQ | Healthcare | $14.77 | 1.9B | n/a | -18.2% | +33.7% | Data only |
| ADMA | ADMA Biologics, Inc. Biotechnology | US / NASDAQ | Healthcare | $8.17 | 1.9B | 12.0x | +43.3% | -65.4% | Data only |
| SGRY | Surgery Partners, Inc. Medical Care Facilities | US / NASDAQ | Healthcare | $14.44 | 1.9B | n/a | +2.7% | -37.7% | Data only |
| LKFT | Lakefront Biotherapeutics NV Biotechnology | US / NASDAQ | Healthcare | $28.59 | 1.9B | 3.3x | +16.3% | +10.8% | Data only |
| ANIP | ANI Pharmaceuticals, Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | $81.86 | 1.9B | 21.0x | +18.3% | +15.6% | Data only |
| PGNY | Progyny, Inc. Healthcare Plans | US / NASDAQ | Healthcare | $23.72 | 1.8B | 31.0x | +14.9% | +1.3% | Data only |
| ADUS | Addus HomeCare Corporation Medical Care Facilities | US / NASDAQ | Healthcare | $99.57 | 1.8B | 18.4x | +9.4% | -11.3% | Data only |
| RAPP | Rapport Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $38.04 | 1.8B | n/a | -28.3% | +272.2% | Data only |
| HRMY | Harmony Biosciences Holdings, Inc. Biotechnology | US / NASDAQ | Healthcare | $30.99 | 1.8B | 12.5x | +17.9% | -7.3% | Data only |
| UFPT | UFP Technologies, Inc. Medical Devices | US / NASDAQ | Healthcare | $231 | 1.8B | 26.3x | +17.2% | +5.0% | Data only |
| RXRX | Recursion Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $3.32 | 1.8B | n/a | -57.2% | -20.8% | Data only |
| ZYME | Zymeworks Inc. Biotechnology | US / NASDAQ | Healthcare | $23.89 | 1.8B | n/a | -42.0% | +110.7% | Data only |
| CAPR | Capricor Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $30.38 | 1.8B | n/a | -46.6% | +340.9% | Data only |
| QURE | uniQure N.V. Biotechnology | US / NASDAQ | Healthcare | $27.66 | 1.7B | n/a | -228.2% | +174.9% | Data only |
| GENB | Generate Biomedicines, Inc. Biotechnology | US / NASDAQ | Healthcare | $13.66 | 1.7B | n/a | n/a | n/a | Data only |
| PVLA | Palvella Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $121 | 1.7B | n/a | -34.2% | +449.6% | Data only |
| VRDN | Viridian Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $16.61 | 1.7B | n/a | -58.1% | +35.2% | Data only |
| VCEL | Vericel Corporation Biotechnology | US / NASDAQ | Healthcare | $33.46 | 1.7B | 79.4x | +6.6% | -17.3% | Data only |
| NRIX | Nurix Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $16.52 | 1.7B | n/a | -61.4% | +77.6% | Data only |
| AHG | Akso Health Group Medical Distribution | US / NASDAQ | Healthcare | $1.98 | 1.7B | n/a | -68.3% | +43.6% | Data only |
| INVA | Innoviva, Inc. Biotechnology | US / NASDAQ | Healthcare | $22.89 | 1.7B | 4.0x | +50.7% | +22.1% | Data only |
| ARDX | Ardelyx, Inc. Biotechnology | US / NASDAQ | Healthcare | $6.78 | 1.7B | n/a | -39.5% | +83.2% | Data only |
| NVAX | Novavax, Inc. Biotechnology | US / NASDAQ | Healthcare | $10.11 | 1.7B | n/a | n/a | +69.9% | Data only |
| AGIO | Agios Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $27.79 | 1.7B | n/a | -32.8% | -1.5% | Data only |
| CLOV | Clover Health Investments, Corp. Healthcare Plans | US / NASDAQ | Healthcare | $3.12 | 1.6B | n/a | -16.9% | -17.2% | Data only |
| GLUE | Monte Rosa Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $19.39 | 1.6B | n/a | -32.6% | +403.6% | Data only |
| AMLX | Amylyx Pharmaceuticals, Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | $14.73 | 1.6B | n/a | -63.3% | +202.5% | Data only |
| ALMR | Alamar Biosciences, Inc. Medical Instruments & Supplies | US / NASDAQ | Healthcare | $23.96 | 1.6B | n/a | -33.6% | n/a | Data only |